Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Ocuphire Pharma Inc. buy El_Zocko

Ocuphire Pharma Inc.
Start price
€3,790.1
27.02.15 / 50%
Target price
€4,896.0
07.04.15
Performance (%)
-3.80%
End price
€3,646.1
07.04.15
Summary
This prediction ended on 07.04.15 with a price of €3,646.1. With a performance of -3.80%, the BUY prediction for Ocuphire Pharma Inc. by El_Zocko closed slightly in the red. El_Zocko has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Ocuphire Pharma Inc. -1.264% -1.264% -64.041% -66.039%
iShares Core DAX® 1.395% -0.696% 15.472% 15.907%
iShares Nasdaq 100 2.287% 7.501% 34.748% 53.474%
iShares Nikkei 225® 1.617% 2.769% 11.442% 8.194%
iShares S&P 500 0.659% 4.280% 26.778% 45.322%

Comments by El_Zocko for this prediction

In the thread Ocuphire Pharma Inc. diskutieren
Prediction Buy
Perf. (%) -3.80%
Target price 1224.000
Change
Ends at 07.04.15

REXAHN PHARMACEUTICALS

Rexahn Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to developing the next generation of targeted therapeutics for the treatment of cancer.
Rexahn's clinical development programs target specific proteins that are selectively localized in human cancer cells and not in healthy tissues resulting in increased efficacy and reduced toxicity.

 

http://www.rexahn.com/cms/

El_Zocko 
0
Report Share
27.02.15
Prediction Buy
Perf. (%) -3.80%
Target price 1224.000
Change
Ends at 07.04.15

(Vom Mitglied beendet)

El_Zocko 
0
Report Share
07.04.15